BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7544790)

  • 1. Osmotic loading of neutralizing antibodies demonstrates a role for protein-tyrosine phosphatase 1B in negative regulation of the insulin action pathway.
    Ahmad F; Li PM; Meyerovitch J; Goldstein BJ
    J Biol Chem; 1995 Sep; 270(35):20503-8. PubMed ID: 7544790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases.
    Ahmad F; Goldstein BJ
    J Cell Biochem; 1997 Jan; 64(1):117-27. PubMed ID: 9015760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell density-dependent changes in the insulin action pathway: evidence for involvement of protein-tyrosine phosphatases.
    Li PM; Goldstein BJ
    J Cell Biochem; 1996 Apr; 61(1):31-8. PubMed ID: 8726353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary complex with the Grb2 adaptor protein.
    Goldstein BJ; Bittner-Kowalczyk A; White MF; Harbeck M
    J Biol Chem; 2000 Feb; 275(6):4283-9. PubMed ID: 10660596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation and activation of protein tyrosine phosphatase (PTP) 1B by insulin receptor.
    Dadke S; Kusari A; Kusari J
    Mol Cell Biochem; 2001 May; 221(1-2):147-54. PubMed ID: 11506178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental switch from prolonged insulin action to increased insulin sensitivity in protein tyrosine phosphatase 1B-deficient hepatocytes.
    Gonzalez-Rodriguez A; Clampit JE; Escribano O; Benito M; Rondinone CM; Valverde AM
    Endocrinology; 2007 Feb; 148(2):594-608. PubMed ID: 17068137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein tyrosine phosphatase 1B interacts with the activated insulin receptor.
    Seely BL; Staubs PA; Reichart DR; Berhanu P; Milarski KL; Saltiel AR; Kusari J; Olefsky JM
    Diabetes; 1996 Oct; 45(10):1379-85. PubMed ID: 8826975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiazolidine derivatives ameliorate high glucose-induced insulin resistance via the normalization of protein-tyrosine phosphatase activities.
    Maegawa H; Ide R; Hasegawa M; Ugi S; Egawa K; Iwanishi M; Kikkawa R; Shigeta Y; Kashiwagi A
    J Biol Chem; 1995 Mar; 270(13):7724-30. PubMed ID: 7535776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin receptor and epidermal growth factor receptor dephosphorylation by three major rat liver protein-tyrosine phosphatases expressed in a recombinant bacterial system.
    Hashimoto N; Zhang WR; Goldstein BJ
    Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):569-76. PubMed ID: 1599438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice.
    Gum RJ; Gaede LL; Koterski SL; Heindel M; Clampit JE; Zinker BA; Trevillyan JM; Ulrich RG; Jirousek MR; Rondinone CM
    Diabetes; 2003 Jan; 52(1):21-8. PubMed ID: 12502489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade.
    Mahadev K; Zilbering A; Zhu L; Goldstein BJ
    J Biol Chem; 2001 Jun; 276(24):21938-42. PubMed ID: 11297536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-tyrosine-phosphatase 1B activation is regulated developmentally in muscle of neonatal pigs.
    Suryawan A; Davis TA
    Am J Physiol Endocrinol Metab; 2003 Jan; 284(1):E47-54. PubMed ID: 12388170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin stimulates tyrosine phosphorylation and inactivation of protein-tyrosine phosphatase 1B in vivo.
    Tao J; Malbon CC; Wang HY
    J Biol Chem; 2001 Aug; 276(31):29520-5. PubMed ID: 11395511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of insulin receptor activation by overexpression of the protein-tyrosine phosphatase LAR in hepatoma cells.
    Li PM; Zhang WR; Goldstein BJ
    Cell Signal; 1996 Nov; 8(7):467-73. PubMed ID: 9023010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 60-kilodalton protein in rat hepatoma cells overexpressing insulin receptor was tyrosine phosphorylated and associated with Syp, phophatidylinositol 3-kinase, and Grb2 in an insulin-dependent manner.
    Zhang-Sun G; Yang C; Viallet J; Feng G; Bergeron JJ; Posner BI
    Endocrinology; 1996 Jul; 137(7):2649-58. PubMed ID: 8770882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of in vitro interactions of protein tyrosine phosphatase 1B with insulin receptors.
    Wang XY; Bergdahl K; Heijbel A; Liljebris C; Bleasdale JE
    Mol Cell Endocrinol; 2001 Feb; 173(1-2):109-20. PubMed ID: 11223182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of protein-tyrosine phosphatase-1B increases insulin signaling in FAO hepatoma cells.
    Clampit JE; Meuth JL; Smith HT; Reilly RM; Jirousek MR; Trevillyan JM; Rondinone CM
    Biochem Biophys Res Commun; 2003 Jan; 300(2):261-7. PubMed ID: 12504077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action.
    Zabolotny JM; Haj FG; Kim YB; Kim HJ; Shulman GI; Kim JK; Neel BG; Kahn BB
    J Biol Chem; 2004 Jun; 279(23):24844-51. PubMed ID: 15031294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-tyrosine phosphatase-1B negatively regulates insulin signaling in l6 myocytes and Fao hepatoma cells.
    Egawa K; Maegawa H; Shimizu S; Morino K; Nishio Y; Bryer-Ash M; Cheung AT; Kolls JK; Kikkawa R; Kashiwagi A
    J Biol Chem; 2001 Mar; 276(13):10207-11. PubMed ID: 11136729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling.
    Kenner KA; Anyanwu E; Olefsky JM; Kusari J
    J Biol Chem; 1996 Aug; 271(33):19810-6. PubMed ID: 8702689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.